During the past decade, Sagara Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 15 clinical trials were completed, i.e. on average, 107.1% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sagara Hospital" #1 sponsor was "Hoffmann-La Roche" with 8 trials, followed by "Pfizer" with 6 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored and "ETOP IBCSG Partners Foundation" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sagara Hospital" #1 collaborator was "Breast International Group" with 3 trials as a collaborator, "Genentech, Inc." with 2 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Frontier Science & Technology Research Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Sagara Hospital" are "Breast Cancer" (8 trials), "Breast Neoplasms" (5 trials), "Metastatic Breast Cancer" (3 trials), "Neoplasms" (2 trials) and "Triple Negative Breast Cancer" (2 trials). Many other conditions were trialed in "Sagara Hospital" in a lesser frequency.

Most popular intervention types in "Sagara Hospital" are "Drug" (23 trials), "Biological" (1 trials), "Other" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (6 trials), "Placebo" (6 trials), "Cyclophosphamide" (4 trials), "Docetaxel" (4 trials) and "Abemaciclib" (3 trials). Other intervention names were less common.

The vast majority of trials in "Sagara Hospital" are 14 trials for "All" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Sagara Hospital". undefined are not yet recruiting, 1 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Sagara Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sagara Hospital, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".